Product category:
Laboratory information management system (LIMS)
News Release from: Aperio Technologies | Subject: TMALab II
Edited by the Laboratorytalk Editorial
Team on 26 July 2007
Digital pathology for tissue microarray
analysis
Aperio Technologies has launched TMALab II, the latest release of its web-based digital pathology information management system, built specifically for researchers who use tissue microarrays (TMAs)
TMALab II software enables researchers to analyse and manage hundreds of small tissue samples simultaneously in a meaningful way to facilitate leading research applications such as new biomarker validation, or discovering and dissecting molecular pathways The software is said to be the only web-based product that facilitates multi-user access and server-based image analysis, allowing numerous remote pathologists to collaborate on large TMA projects
This article was originally published on Laboratorytalk on 31 Aug 2006 at 8.00am (UK)
Related stories
Aperio announces Pathology Visions Europe 2006
Aperio Technologies, a provider of digital pathology systems to the healthcare IT industry, announces a conference on Digital Pathology Solutions to be held in Leeds, UK, 7-8 November 2006
High-res slide scanning to digitise blood smear
Aperio Technologies's high-resolution slide scanning capability gives haematopathologists and microbiologists the ability to digitise blood smear, Gram stain and other microscopic specimens
Researchers can easily retrieve all stains for any given core, and all cores for any given specimen.
Additionally, the software provides links from any TMA core back to the original H+E slide cut from the corresponding donor block.
"Our first generation TMALab product has been successfully assisting scores of TMA researchers to streamline high-throughput tissue analysis in both the bio-pharma and cancer research arenas for many years," stated Dirk Soenksen, CEO of Aperio.
"TMALab II enhances the value of our digital pathology solution, sets new standards for ease of integration, and significantly expands data analysis and reporting capabilities for the TMA environment".
Beta versions of the software have been successfully deployed at the National Cancer Institute in Bethesda, USA, and the Netherlands Cancer Institute in Amsterdam.
TMALab II is currently being used at the National Cancer Institute's tissue array research programme led by Stephen Hewitt.
The initial project involves multiple slides prepared from 32 tissue microarrays.
The TMA slides will be scanned using an Aperio ScanScope, annotated by a pathologist accessing the software via the Internet, and scored using quantitative image analysis algorithms.
Additional projects have already been initiated using the platform to examine more than 75 stains on a single TMA.
TMALab II is fully integrated into Aperio's patented linear array-based ScanScope slide scanning system and Spectrum digital pathology information management software so that for the first time ever, researchers are able to manage digital whole slide- based projects along side TMA projects all within a single unified database containing specimen, digital slide, and TMA core information.
In addition to data management and image retrieval, the software also enables server-based image analysis using any one of Aperio's popular IHC algorithms or any compatible third party algorithms.
• Aperio Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
